Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Marbach JA"" wg kryterium: Autor


Wyświetlanie 1-19 z 19
Tytuł:
Diagnostic accuracy of point-of-care ultrasound with artificial intelligence-assisted assessment of left ventricular ejection fraction.
Autorzy:
Motazedian P; CAPITAL Research Group, Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.; Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.; School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada.
Marbach JA; Division of Cardiology, Knight Cardiovascular Institute, Oregon Health and Sciences University, Portland, OR, USA.
Prosperi-Porta G; CAPITAL Research Group, Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.; Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Parlow S; CAPITAL Research Group, Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.; Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Di Santo P; CAPITAL Research Group, Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.; School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada.; Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
Abdel-Razek O; CAPITAL Research Group, Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.; Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Jung R; CAPITAL Research Group, Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.; Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
Bradford WB; Division of Cardiology, Tufts Medical Center and Tufts University School of Medicine, Boston, MA, USA.
Tsang M; Division of Cardiology, Tufts Medical Center and Tufts University School of Medicine, Boston, MA, USA.
Hyon M; Division of Cardiology, Tufts Medical Center and Tufts University School of Medicine, Boston, MA, USA.
Pacifici S; Division of Cardiology, Tufts Medical Center and Tufts University School of Medicine, Boston, MA, USA.
Mohanty S; Division of Cardiology, Tufts Medical Center and Tufts University School of Medicine, Boston, MA, USA.
Ramirez FD; Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Huggins GS; Division of Cardiology, Tufts Medical Center and Tufts University School of Medicine, Boston, MA, USA.
Simard T; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.
Hon S; Division of Pulmonary and Critical Care Medicine, Tufts Medical Center and Tufts University School of Medicine, Boston, MA, USA.
Hibbert B; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA. .
Pokaż więcej
Źródło:
NPJ digital medicine [NPJ Digit Med] 2023 Oct 28; Vol. 6 (1), pp. 201. Date of Electronic Publication: 2023 Oct 28.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Formalized Research Training Increases Fellowship and Early Career Academic Productivity: A Five-Year Follow-up.
Autorzy:
Abdel-Razek O; CAPITAL Research Group, Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Marbach JA; CAPITAL Research Group, Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; Knight Cardiovascular Center, Division of Cardiovascular Medicine, Oregon Health and Science University, Portland, Oregon, USA.
Simard T; CAPITAL Research Group, Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; Department of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota, USA.
Almufleh A; CAPITAL Research Group, Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; Division of Cardiology, Queens University, Kingston, Ontario, Canada.
Di Santo P; CAPITAL Research Group, Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; Vascular Biology and Experimental Medicine Laboratory, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada; Department of Medicine, Division of Critical Care, University of Ottawa, Ottawa, Ontario, Canada.
Jung R; CAPITAL Research Group, Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; Vascular Biology and Experimental Medicine Laboratory, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada.
Parlow S; CAPITAL Research Group, Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; Department of Medicine, Division of Critical Care, University of Ottawa, Ottawa, Ontario, Canada.
Mathew R; CAPITAL Research Group, Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; Vascular Biology and Experimental Medicine Laboratory, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Hibbert B; CAPITAL Research Group, Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; Department of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota, USA.
Froeschl M; CAPITAL Research Group, Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada. Electronic address: .
Pokaż więcej
Źródło:
The Canadian journal of cardiology [Can J Cardiol] 2023 Oct; Vol. 39 (10), pp. 1310-1312. Date of Electronic Publication: 2023 May 05.
Typ publikacji:
Letter
Opinia redakcyjna
Tytuł:
Efficacy of Milrinone and Dobutamine in Cardiogenic Shock: An Updated Systematic Review and Meta-Analysis.
Autorzy:
Abdel-Razek O; CAPITAL Research Group, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.; Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Di Santo P; CAPITAL Research Group, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.; Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.; Vascular Biology and Experimental Medicine Laboratory, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.; School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada.
Jung RG; CAPITAL Research Group, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.; Vascular Biology and Experimental Medicine Laboratory, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.; Department of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.; Division of Internal Medicine, The Ottawa Hospital, Ottawa, Ontario, Canada.
Parlow S; CAPITAL Research Group, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.; Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Motazedian P; CAPITAL Research Group, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.; Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Prosperi-Porta G; CAPITAL Research Group, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.; Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Visintini S; Berkman Library, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Marbach JA; Division of Cardiovascular Medicine, Knight Cardiovascular Center, Oregon Health and Science University, Portland, OR.
Ramirez FD; CAPITAL Research Group, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.; Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Simard T; CAPITAL Research Group, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.; Vascular Biology and Experimental Medicine Laboratory, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.; Department of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN.
Labinaz M; CAPITAL Research Group, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.; Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Mathew R; CAPITAL Research Group, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.; Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Hibbert B; CAPITAL Research Group, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN.
Pokaż więcej
Źródło:
Critical care explorations [Crit Care Explor] 2023 Aug 28; Vol. 5 (9), pp. e0962. Date of Electronic Publication: 2023 Aug 28 (Print Publication: 2023).
Typ publikacji:
Journal Article; Review
Czasopismo naukowe
Tytuł:
Inotrope versus placebo therapy in cardiogenic shock: Rationale and study design of the CAPITAL DOREMI2 trial.
Autorzy:
Parlow S; Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; CAPITAL Research Group, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Santo PD; Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; CAPITAL Research Group, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; Division of Critical Care Medicine, Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada; School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada.
Sterling LH; Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; CAPITAL Research Group, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Goodliffe L; Division of Cardiology, Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Motazedian P; Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; CAPITAL Research Group, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Prosperi-Porta G; Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Morgan B; CAPITAL Research Group, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Koopman Z; CAPITAL Research Group, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Jung RG; CAPITAL Research Group, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
Lepage-Ratte MF; CAPITAL Research Group, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
Robinson L; CAPITAL Research Group, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Feagan H; CAPITAL Research Group, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Simard T; Department of Cardiovascular Diseases, Mayo Clinic School of Medicine, Rochester, Minnesota.
Wells GA; School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada; Cardiovascular Research Methods Center, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Kyeremanteng K; Division of Critical Care Medicine, Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
Ainsworth C; Division of Cardiology, Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Amin F; Division of Cardiology, Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Marbach JA; Division of Cardiology, Knight Cardiovascular Institute, Oregon Health & Sciences University, Portland, Oregon, USA.
Fernando SM; Department of Critical Care, Lakeridge Health Corporation, Oshawa, Ontario, Canada.
Labinaz M; Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; CAPITAL Research Group, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Belley-Cote EP; Division of Cardiology, Department of Medicine, McMaster University, Hamilton, Ontario, Canada; Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada.
Hibbert B; Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; CAPITAL Research Group, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Mathew R; Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; CAPITAL Research Group, University of Ottawa Heart Institute, Ottawa, Ontario, Canada. Electronic address: .
Pokaż więcej
Źródło:
American heart journal [Am Heart J] 2023 Aug; Vol. 262, pp. 83-89. Date of Electronic Publication: 2023 Apr 23.
Typ publikacji:
Randomized Controlled Trial; Multicenter Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Shock, Cardiogenic*/therapy
Shock, Cardiogenic*/drug therapy
Heart Arrest*/complications
Humans ; Hospital Mortality ; Vasoconstrictor Agents/therapeutic use ; Double-Blind Method ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Arrhythmic Events and Mortality in Patients With Cardiogenic Shock on Inotropic Support: Results of the DOREMI Randomized Trial.
Autorzy:
Jung RG; CAPITAL Research Group, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario Canada.
Di Santo P; CAPITAL Research Group, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada.
Mathew R; CAPITAL Research Group, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Simard T; CAPITAL Research Group, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; Division of Cardiology, Mayo Clinic, Rochester, Minnesota, USA.
Parlow S; CAPITAL Research Group, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Weng W; Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Abdel-Razek O; CAPITAL Research Group, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Malhotra N; CAPITAL Research Group, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Cheung M; CAPITAL Research Group, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Hutson JH; CAPITAL Research Group, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; Division of Critical Care, University of Ottawa, Ottawa, Ontario, Canada.
Marbach JA; CAPITAL Research Group, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; Division of Cardiology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Motazedian P; CAPITAL Research Group, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Thibert MJ; Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Fernando SM; Division of Critical Care, University of Ottawa, Ottawa, Ontario, Canada.
Nery PB; Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Nair GM; Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Russo JJ; CAPITAL Research Group, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Hibbert B; CAPITAL Research Group, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario Canada.
Ramirez FD; CAPITAL Research Group, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada. Electronic address: .
Pokaż więcej
Źródło:
The Canadian journal of cardiology [Can J Cardiol] 2023 Apr; Vol. 39 (4), pp. 394-402. Date of Electronic Publication: 2022 Sep 20.
Typ publikacji:
Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Shock, Cardiogenic*/etiology
Dobutamine*/therapeutic use
Humans ; Milrinone/therapeutic use ; Stroke Volume ; Ventricular Function, Left ; Arrhythmias, Cardiac/chemically induced
Czasopismo naukowe
Tytuł:
Strategies to reduce limb ischemia in peripheral venoarterial extracorporeal membrane oxygenation: A systematic review and Meta-analysis.
Autorzy:
Marbach JA; Division of Pulmonary, Critical Care and Sleep Medicine, Tufts Medical Center and Tufts University School of Medicine, United States of America; CAPITAL Research Group, Division of Cardiology, Department of Medicine, University of Ottawa Heart Institute, United States of America; The Cardiovascular Center, Tufts Medical Center and Tufts University School of Medicine, United States of America.
Faugno AJ; Division of Pulmonary, Critical Care and Sleep Medicine, Tufts Medical Center and Tufts University School of Medicine, United States of America; The Cardiovascular Center, Tufts Medical Center and Tufts University School of Medicine, United States of America.
Pacifici S; Department of Medicine, Tufts Medical Center and Tufts University School of Medicine, United States of America.
Chweich H; Division of Pulmonary, Critical Care and Sleep Medicine, Tufts Medical Center and Tufts University School of Medicine, United States of America; The Cardiovascular Center, Tufts Medical Center and Tufts University School of Medicine, United States of America.
Marbach JK; Department of Nursing, Tufts Medical Center, United States of America.
Rabinowitz JB; Hirsh Health Sciences Library, Tufts University, United States of America.
Thayer KL; The Cardiovascular Center, Tufts Medical Center and Tufts University School of Medicine, United States of America.
Di Santo P; CAPITAL Research Group, Division of Cardiology, Department of Medicine, University of Ottawa Heart Institute, United States of America.
Kapur NK; Department of Medicine, Tufts Medical Center and Tufts University School of Medicine, United States of America; The Cardiovascular Center, Tufts Medical Center and Tufts University School of Medicine, United States of America. Electronic address: .
Pokaż więcej
Źródło:
International journal of cardiology [Int J Cardiol] 2022 Aug 15; Vol. 361, pp. 77-84. Date of Electronic Publication: 2022 May 09.
Typ publikacji:
Journal Article; Meta-Analysis; Review; Systematic Review
MeSH Terms:
Catheterization, Peripheral*/adverse effects
Extracorporeal Membrane Oxygenation*/adverse effects
Peripheral Vascular Diseases*
Femoral Artery ; Humans ; Ischemia/diagnosis ; Ischemia/prevention & control ; Retrospective Studies ; Risk Factors ; Shock, Cardiogenic/complications ; Shock, Cardiogenic/diagnosis ; Shock, Cardiogenic/therapy
Czasopismo naukowe
Tytuł:
Left Ventricular Unloading Before Percutaneous Coronary Intervention is Associated With Improved Survival in Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock: A Systematic Review and Meta-Analysis.
Autorzy:
Miyashita S; Department of Medicine, Tufts Medical Center and Tufts University School of Medicine, USA; Cardiovascular Center, Tufts Medical Center and Tufts University School of Medicine, USA.
Banlengchit R; Department of Medicine, Tufts Medical Center and Tufts University School of Medicine, USA.
Marbach JA; Division of Pulmonary, Critical Care and Sleep Medicine, Tufts Medical Center and Tufts University School of Medicine, USA.
Chweich H; Division of Pulmonary, Critical Care and Sleep Medicine, Tufts Medical Center and Tufts University School of Medicine, USA.
Kawabori M; Department of Medicine, Tufts Medical Center and Tufts University School of Medicine, USA; Cardiovascular Center, Tufts Medical Center and Tufts University School of Medicine, USA.
Kimmelstiel CD; Department of Medicine, Tufts Medical Center and Tufts University School of Medicine, USA; Cardiovascular Center, Tufts Medical Center and Tufts University School of Medicine, USA.
Kapur NK; Department of Medicine, Tufts Medical Center and Tufts University School of Medicine, USA; Cardiovascular Center, Tufts Medical Center and Tufts University School of Medicine, USA. Electronic address: .
Pokaż więcej
Źródło:
Cardiovascular revascularization medicine : including molecular interventions [Cardiovasc Revasc Med] 2022 Jun; Vol. 39, pp. 28-35. Date of Electronic Publication: 2021 Nov 10.
Typ publikacji:
Journal Article; Meta-Analysis; Review; Systematic Review
MeSH Terms:
Heart-Assist Devices*/adverse effects
Myocardial Infarction*/complications
Myocardial Infarction*/therapy
Percutaneous Coronary Intervention*/adverse effects
Heart Ventricles ; Humans ; Retrospective Studies ; Shock, Cardiogenic/diagnosis ; Shock, Cardiogenic/etiology ; Shock, Cardiogenic/therapy ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Lactate Clearance as a Surrogate for Mortality in Cardiogenic Shock: Insights From the DOREMI Trial.
Autorzy:
Marbach JA; CAPITAL Research Group Division of Cardiology Department of Medicine University of Ottawa Heart Institute Ottawa Canada.; Division of Pulmonary Critical Care and Sleep Medicine Tufts Medical Center and Tufts University School of Medicine Boston MA.; Division of Cardiology Beth Israel Deaconess Medical Center Boston MA.
Di Santo P; CAPITAL Research Group Division of Cardiology Department of Medicine University of Ottawa Heart Institute Ottawa Canada.; Faculty of Medicine University of Ottawa Canada.; School of Epidemiology and Public Health University of Ottawa Canada.
Kapur NK; Department of Medicine Tufts Medical Center and Tufts University School of Medicine Boston MA.; The Cardiovascular Center Tufts Medical Center and Tufts University School of Medicine Boston MA.
Thayer KL; The Cardiovascular Center Tufts Medical Center and Tufts University School of Medicine Boston MA.
Simard T; CAPITAL Research Group Division of Cardiology Department of Medicine University of Ottawa Heart Institute Ottawa Canada.; Division of Cardiology Mayo Clinic Rochester MN.
Jung RG; CAPITAL Research Group Division of Cardiology Department of Medicine University of Ottawa Heart Institute Ottawa Canada.; Faculty of Medicine University of Ottawa Canada.; Department of Cellular and Molecular Medicine University of Ottawa Canada.
Parlow S; CAPITAL Research Group Division of Cardiology Department of Medicine University of Ottawa Heart Institute Ottawa Canada.; Faculty of Medicine University of Ottawa Canada.
Abdel-Razek O; CAPITAL Research Group Division of Cardiology Department of Medicine University of Ottawa Heart Institute Ottawa Canada.; Faculty of Medicine University of Ottawa Canada.
Fernando SM; Faculty of Medicine University of Ottawa Canada.; Division of Critical Care Department of Medicine University of Ottawa Canada.
Labinaz M; CAPITAL Research Group Division of Cardiology Department of Medicine University of Ottawa Heart Institute Ottawa Canada.; Faculty of Medicine University of Ottawa Canada.
Froeschl M; CAPITAL Research Group Division of Cardiology Department of Medicine University of Ottawa Heart Institute Ottawa Canada.; Faculty of Medicine University of Ottawa Canada.
Mathew R; CAPITAL Research Group Division of Cardiology Department of Medicine University of Ottawa Heart Institute Ottawa Canada.; Faculty of Medicine University of Ottawa Canada.; Division of Critical Care Department of Medicine University of Ottawa Canada.
Hibbert B; CAPITAL Research Group Division of Cardiology Department of Medicine University of Ottawa Heart Institute Ottawa Canada.; Faculty of Medicine University of Ottawa Canada.; Department of Cellular and Molecular Medicine University of Ottawa Canada.
Pokaż więcej
Źródło:
Journal of the American Heart Association [J Am Heart Assoc] 2022 Mar 15; Vol. 11 (6), pp. e023322. Date of Electronic Publication: 2022 Mar 09.
Typ publikacji:
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Milrinone*/therapeutic use
Shock, Cardiogenic*/diagnosis
Shock, Cardiogenic*/drug therapy
Dobutamine/therapeutic use ; Hospital Mortality ; Humans ; Lactic Acid/therapeutic use
Czasopismo naukowe
Tytuł:
Implications of Myocardial Infarction on Management and Outcome in Cardiogenic Shock.
Autorzy:
Jung RG; CAPITAL Research Group Division of Cardiology University of Ottawa Heart Institute Ottawa Ontario Canada.; Faculty of Medicine University of Ottawa Ontario Canada.; Department of Cellular and Molecular Medicine University of Ottawa Ontario Canada.
Di Santo P; CAPITAL Research Group Division of Cardiology University of Ottawa Heart Institute Ottawa Ontario Canada.; School of Epidemiology and Public Health University of Ottawa Ontario Canada.; Division of Cardiology University of Ottawa Heart Institute Ottawa Ontario Canada.
Mathew R; CAPITAL Research Group Division of Cardiology University of Ottawa Heart Institute Ottawa Ontario Canada.; Division of Cardiology University of Ottawa Heart Institute Ottawa Ontario Canada.; Division of Critical Care Department of Medicine University of Ottawa Ontario Canada.
Abdel-Razek O; CAPITAL Research Group Division of Cardiology University of Ottawa Heart Institute Ottawa Ontario Canada.; Division of Cardiology University of Ottawa Heart Institute Ottawa Ontario Canada.
Parlow S; CAPITAL Research Group Division of Cardiology University of Ottawa Heart Institute Ottawa Ontario Canada.; Division of Cardiology University of Ottawa Heart Institute Ottawa Ontario Canada.
Simard T; CAPITAL Research Group Division of Cardiology University of Ottawa Heart Institute Ottawa Ontario Canada.; Department of Cellular and Molecular Medicine University of Ottawa Ontario Canada.; Division of Cardiology University of Ottawa Heart Institute Ottawa Ontario Canada.; Department of Cardiovascular Medicine Mayo Clinic Rochester MN.
Marbach JA; CAPITAL Research Group Division of Cardiology University of Ottawa Heart Institute Ottawa Ontario Canada.; Division of Critical Care Tufts Medical Center Boston MA.
Gillmore T; Faculty of Medicine University of Ottawa Ontario Canada.
Mao B; Faculty of Medicine University of Ottawa Ontario Canada.
Bernick J; Cardiovascular Research Methods Centre University of Ottawa Heart Institute Ottawa Canada.
Theriault-Lauzier P; CAPITAL Research Group Division of Cardiology University of Ottawa Heart Institute Ottawa Ontario Canada.; Division of Cardiology University of Ottawa Heart Institute Ottawa Ontario Canada.
Fu A; CAPITAL Research Group Division of Cardiology University of Ottawa Heart Institute Ottawa Ontario Canada.; Division of Cardiology University of Ottawa Heart Institute Ottawa Ontario Canada.
Lau L; CAPITAL Research Group Division of Cardiology University of Ottawa Heart Institute Ottawa Ontario Canada.; Division of Cardiology University of Ottawa Heart Institute Ottawa Ontario Canada.
Motazedian P; University of Calgary Alberta Canada.
Russo JJ; CAPITAL Research Group Division of Cardiology University of Ottawa Heart Institute Ottawa Ontario Canada.; Division of Cardiology University of Ottawa Heart Institute Ottawa Ontario Canada.
Labinaz M; CAPITAL Research Group Division of Cardiology University of Ottawa Heart Institute Ottawa Ontario Canada.; Division of Cardiology University of Ottawa Heart Institute Ottawa Ontario Canada.
Hibbert B; CAPITAL Research Group Division of Cardiology University of Ottawa Heart Institute Ottawa Ontario Canada.; Department of Cellular and Molecular Medicine University of Ottawa Ontario Canada.; School of Epidemiology and Public Health University of Ottawa Ontario Canada.; Division of Cardiology University of Ottawa Heart Institute Ottawa Ontario Canada.
Pokaż więcej
Źródło:
Journal of the American Heart Association [J Am Heart Assoc] 2021 Nov 02; Vol. 10 (21), pp. e021570. Date of Electronic Publication: 2021 Oct 29.
Typ publikacji:
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Heart Arrest*
Myocardial Infarction*/complications
Myocardial Infarction*/therapy
Dobutamine ; Humans ; Milrinone ; Percutaneous Coronary Intervention/adverse effects ; Shock, Cardiogenic/diagnosis ; Shock, Cardiogenic/etiology ; Shock, Cardiogenic/therapy ; Stroke ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Lactate Clearance Is Associated With Improved Survival in Cardiogenic Shock: A Systematic Review and Meta-Analysis of Prognostic Factor Studies.
Autorzy:
Marbach JA; The Cardiovascular Center, Tufts Medical Center and Tufts University School of Medicine, Boston, Massachusetts; Division of Pulmonary, Critical Care and Sleep Medicine, Tufts Medical Center and Tufts University School of Medicine, Boston, Massachusetts.
Stone S; Department of Medicine, Tufts Medical Center and Tufts University School of Medicine, Boston, Massachusetts.
Schwartz B; Department of Medicine, Tufts Medical Center and Tufts University School of Medicine, Boston, Massachusetts.
Pahuja M; Division of Cardiology, Medstar Georgetown University / Washington Hospital Center, Washington, DC.
Thayer KL; Department of Medicine, Tufts Medical Center and Tufts University School of Medicine, Boston, Massachusetts.
Faugno AJ; Division of Pulmonary, Critical Care and Sleep Medicine, Tufts Medical Center and Tufts University School of Medicine, Boston, Massachusetts.
Chweich H; Division of Pulmonary, Critical Care and Sleep Medicine, Tufts Medical Center and Tufts University School of Medicine, Boston, Massachusetts.
Rabinowitz JB; Hirsh Health Sciences Library, Tufts University, Boston, Massachusetts.
Kapur NK; The Cardiovascular Center, Tufts Medical Center and Tufts University School of Medicine, Boston, Massachusetts; Department of Medicine, Tufts Medical Center and Tufts University School of Medicine, Boston, Massachusetts. Electronic address: .
Pokaż więcej
Źródło:
Journal of cardiac failure [J Card Fail] 2021 Oct; Vol. 27 (10), pp. 1082-1089.
Typ publikacji:
Journal Article; Meta-Analysis; Systematic Review
MeSH Terms:
Heart Failure*
Shock, Cardiogenic*/diagnosis
Shock, Cardiogenic*/therapy
Humans ; Lactic Acid ; Prognosis ; Prospective Studies ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Impact of baseline beta-blocker use on inotrope response and clinical outcomes in cardiogenic shock: a subgroup analysis of the DOREMI trial.
Autorzy:
Di Santo P; CAPITAL Research Group, Division of Cardiology, University of Ottawa Heart Institute, 40 Ruskin Street, H-4238, Ottawa, ON, K1Y 4W7, Canada.; Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.; School of Epidemiology and Public Health, University of Ottawa, Ottawa, ON, Canada.
Mathew R; CAPITAL Research Group, Division of Cardiology, University of Ottawa Heart Institute, 40 Ruskin Street, H-4238, Ottawa, ON, K1Y 4W7, Canada.; Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.; Division of Critical Care, Department of Medicine, University of Ottawa, Ottawa, ON, Canada.
Jung RG; CAPITAL Research Group, Division of Cardiology, University of Ottawa Heart Institute, 40 Ruskin Street, H-4238, Ottawa, ON, K1Y 4W7, Canada.; Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.; Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, Canada.
Simard T; CAPITAL Research Group, Division of Cardiology, University of Ottawa Heart Institute, 40 Ruskin Street, H-4238, Ottawa, ON, K1Y 4W7, Canada.; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.
Skanes S; Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.
Mao B; Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.
Ramirez FD; CAPITAL Research Group, Division of Cardiology, University of Ottawa Heart Institute, 40 Ruskin Street, H-4238, Ottawa, ON, K1Y 4W7, Canada.; Hôpital Cardiologique du Haut Lévêque, CHU Bordeaux, Bordeaux-Pessac, France.; LIRYC (L'Institut de Rythmologie Et Modélisation Cardiaque), Bordeaux-Pessac, France.
Marbach JA; CAPITAL Research Group, Division of Cardiology, University of Ottawa Heart Institute, 40 Ruskin Street, H-4238, Ottawa, ON, K1Y 4W7, Canada.; Division of Critical Care, Tufts Medical Center, Boston, MA, USA.
Abdel-Razek O; CAPITAL Research Group, Division of Cardiology, University of Ottawa Heart Institute, 40 Ruskin Street, H-4238, Ottawa, ON, K1Y 4W7, Canada.; Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.
Motazedian P; CAPITAL Research Group, Division of Cardiology, University of Ottawa Heart Institute, 40 Ruskin Street, H-4238, Ottawa, ON, K1Y 4W7, Canada.; Department of Medicine, Cumming School of Medicine, Calgary, AB, Canada.
Parlow S; CAPITAL Research Group, Division of Cardiology, University of Ottawa Heart Institute, 40 Ruskin Street, H-4238, Ottawa, ON, K1Y 4W7, Canada.; Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.
Boczar KE; CAPITAL Research Group, Division of Cardiology, University of Ottawa Heart Institute, 40 Ruskin Street, H-4238, Ottawa, ON, K1Y 4W7, Canada.; Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.; School of Epidemiology and Public Health, University of Ottawa, Ottawa, ON, Canada.
D'Egidio G; Division of Critical Care, Department of Medicine, University of Ottawa, Ottawa, ON, Canada.
Hawken S; Ottawa Hospital Research Institute, Ottawa, ON, Canada.
Bernick J; Cardiovascular Research Methods Centre, University of Ottawa Heart Institute, Ottawa, ON, Canada.
Wells GA; Cardiovascular Research Methods Centre, University of Ottawa Heart Institute, Ottawa, ON, Canada.
Dick A; CAPITAL Research Group, Division of Cardiology, University of Ottawa Heart Institute, 40 Ruskin Street, H-4238, Ottawa, ON, K1Y 4W7, Canada.; Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.
So DY; CAPITAL Research Group, Division of Cardiology, University of Ottawa Heart Institute, 40 Ruskin Street, H-4238, Ottawa, ON, K1Y 4W7, Canada.; Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.
Glover C; CAPITAL Research Group, Division of Cardiology, University of Ottawa Heart Institute, 40 Ruskin Street, H-4238, Ottawa, ON, K1Y 4W7, Canada.; Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.
Russo JJ; CAPITAL Research Group, Division of Cardiology, University of Ottawa Heart Institute, 40 Ruskin Street, H-4238, Ottawa, ON, K1Y 4W7, Canada.; Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.
McGuinty C; CAPITAL Research Group, Division of Cardiology, University of Ottawa Heart Institute, 40 Ruskin Street, H-4238, Ottawa, ON, K1Y 4W7, Canada.; Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.
Hibbert B; CAPITAL Research Group, Division of Cardiology, University of Ottawa Heart Institute, 40 Ruskin Street, H-4238, Ottawa, ON, K1Y 4W7, Canada. .; Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada. .; Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, Canada. .
Pokaż więcej
Corporate Authors:
CAPITAL DOREMI investigators
Źródło:
Critical care (London, England) [Crit Care] 2021 Aug 10; Vol. 25 (1), pp. 289. Date of Electronic Publication: 2021 Aug 10.
Typ publikacji:
Journal Article; Randomized Controlled Trial
MeSH Terms:
Adrenergic beta-Antagonists/*adverse effects
Cardiotonic Agents/*administration & dosage
Outcome Assessment, Health Care/*statistics & numerical data
Shock, Cardiogenic/*drug therapy
Adrenergic beta-Antagonists/pharmacology ; Adrenergic beta-Antagonists/therapeutic use ; Aged ; Aged, 80 and over ; Cardiotonic Agents/therapeutic use ; Dobutamine/adverse effects ; Dobutamine/pharmacology ; Dobutamine/therapeutic use ; Dose-Response Relationship, Drug ; Double-Blind Method ; Female ; Humans ; Male ; Middle Aged ; Milrinone/adverse effects ; Milrinone/pharmacology ; Milrinone/therapeutic use ; Mortality/trends ; Outcome Assessment, Health Care/methods ; Shock, Cardiogenic/physiopathology
Czasopismo naukowe
Tytuł:
Acute kidney injury after radial or femoral artery access in ST-segment elevation myocardial infarction: AKI-SAFARI.
Autorzy:
Marbach JA; CAPITAL Research Group, Division of Cardiology, Department of Medicine, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Wells G; Division of Statistics and Epidemiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Santo PD; CAPITAL Research Group, Division of Cardiology, Department of Medicine, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
So D; CAPITAL Research Group, Division of Cardiology, Department of Medicine, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Chong AY; CAPITAL Research Group, Division of Cardiology, Department of Medicine, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Russo J; CAPITAL Research Group, Division of Cardiology, Department of Medicine, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Labinaz M; CAPITAL Research Group, Division of Cardiology, Department of Medicine, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Dick A; CAPITAL Research Group, Division of Cardiology, Department of Medicine, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Froeschl M; CAPITAL Research Group, Division of Cardiology, Department of Medicine, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Glover C; CAPITAL Research Group, Division of Cardiology, Department of Medicine, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Hibbert B; CAPITAL Research Group, Division of Cardiology, Department of Medicine, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Marquis JF; CAPITAL Research Group, Division of Cardiology, Department of Medicine, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
MacDougall A; Department of Medicine, Thunder Bay Regional Health Sciences Centre, Thunder Bay, Ontario, Canada.
Kass M; Department of Medicine, St. Boniface General Hospital, Winnipeg, Manitoba, Canada.
Paddock V; Department of Medicine, Saint John Regional Hospital, Saint John, New Brunswick, Canada.
Quraishi AUR; Dalhousie University, QE II Health Sciences Centre, Halifax, Nova Scotia, Canada.
Chandrasekhar J; Department of Cardiology, Box Hill Hospital, Eastern Health Clinical School and Monash University, Melbourne, Australia.
Ghosh N; CAPITAL Research Group, Division of Cardiology, Department of Medicine, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Bernick J; Division of Statistics and Epidemiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Le May M; CAPITAL Research Group, Division of Cardiology, Department of Medicine, University of Ottawa Heart Institute, Ottawa, Ontario, Canada. Electronic address: .
Pokaż więcej
Źródło:
American heart journal [Am Heart J] 2021 Apr; Vol. 234, pp. 12-22. Date of Electronic Publication: 2021 Jan 07.
Typ publikacji:
Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Femoral Artery*
Radial Artery*
Acute Kidney Injury/*etiology
Percutaneous Coronary Intervention/*adverse effects
ST Elevation Myocardial Infarction/*surgery
Acute Kidney Injury/blood ; Acute Kidney Injury/epidemiology ; Aged ; Creatinine/blood ; Female ; Humans ; Logistic Models ; Male ; Middle Aged ; Percutaneous Coronary Intervention/methods ; Percutaneous Coronary Intervention/statistics & numerical data
Czasopismo naukowe
Tytuł:
A Novel Protocol for Very Early Hospital Discharge After STEMI.
Autorzy:
Marbach JA; Capital Research Group, Division of Cardiology, Department of Medicine, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Alhassani S; Capital Research Group, Division of Cardiology, Department of Medicine, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Chong AY; Capital Research Group, Division of Cardiology, Department of Medicine, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
MacPhee E; Capital Research Group, Division of Cardiology, Department of Medicine, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Le May M; Capital Research Group, Division of Cardiology, Department of Medicine, University of Ottawa Heart Institute, Ottawa, Ontario, Canada. Electronic address: .
Pokaż więcej
Źródło:
The Canadian journal of cardiology [Can J Cardiol] 2020 Nov; Vol. 36 (11), pp. 1826-1829. Date of Electronic Publication: 2020 Aug 22.
Typ publikacji:
Journal Article
MeSH Terms:
Clinical Protocols*
Perioperative Care*/standards
ST Elevation Myocardial Infarction/*therapy
Humans ; Length of Stay/economics ; Patient Discharge/economics ; Percutaneous Coronary Intervention ; Risk Assessment ; ST Elevation Myocardial Infarction/economics
Czasopismo naukowe
Tytuł:
Female Authorship in Preclinical Cardiovascular Research: Temporal Trends and Influence on Experimental Design.
Autorzy:
Labinaz A; CAPITAL Research Group, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.; Vascular Biology and Experimental Medicine Laboratory, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.; Faculty of Science, University of Ottawa, Ottawa, Ontario, Canada.
Marbach JA; CAPITAL Research Group, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.; Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Jung RG; CAPITAL Research Group, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.; Vascular Biology and Experimental Medicine Laboratory, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.; Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada.; Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
Moreland R; CAPITAL Research Group, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.; Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Motazedian P; CAPITAL Research Group, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.; Department of Medicine, University of Calgary Cumming School of Medicine, Calgary, Alberta, Canada.
Di Santo P; CAPITAL Research Group, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.; Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.; School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada.
Clancy AA; Department of Obstetrics and Gynecology, University of Ottawa, Ottawa, Ontario, Canada.; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
MacDonald Z; Department of Emergency Medicine, University of Ottawa, Ottawa, Ontario, Canada.
Simard T; CAPITAL Research Group, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.; Vascular Biology and Experimental Medicine Laboratory, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.; Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.; Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada.
Hibbert B; CAPITAL Research Group, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.; Vascular Biology and Experimental Medicine Laboratory, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.; Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.; Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada.
Ramirez FD; CAPITAL Research Group, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.; Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.; School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada.
Pokaż więcej
Źródło:
JACC. Basic to translational science [JACC Basic Transl Sci] 2019 Aug 26; Vol. 4 (4), pp. 471-477. Date of Electronic Publication: 2019 Aug 26 (Print Publication: 2019).
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
In-hospital outcomes of STEMI patients on warfarin undergoing primary PCI.
Autorzy:
Marbach JA; The CAPITAL Research Group, Division of Cardiology, Department of Medicine, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Almufleh A; The CAPITAL Research Group, Division of Cardiology, Department of Medicine, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.; Cardiac Sciences Department, King Saud University, Riyadh, Saudi Arabia.
Bernick J; The CAPITAL Research Group, Division of Cardiology, Department of Medicine, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Blondeau M; The CAPITAL Research Group, Division of Cardiology, Department of Medicine, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Osborne C; The CAPITAL Research Group, Division of Cardiology, Department of Medicine, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Russo J; The CAPITAL Research Group, Division of Cardiology, Department of Medicine, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Hibbert B; The CAPITAL Research Group, Division of Cardiology, Department of Medicine, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Froeschl M; The CAPITAL Research Group, Division of Cardiology, Department of Medicine, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Labinaz M; The CAPITAL Research Group, Division of Cardiology, Department of Medicine, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Glover C; The CAPITAL Research Group, Division of Cardiology, Department of Medicine, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Dick A; The CAPITAL Research Group, Division of Cardiology, Department of Medicine, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
So D; The CAPITAL Research Group, Division of Cardiology, Department of Medicine, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Chong AY; The CAPITAL Research Group, Division of Cardiology, Department of Medicine, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Le May M; The CAPITAL Research Group, Division of Cardiology, Department of Medicine, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Pokaż więcej
Źródło:
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions [Catheter Cardiovasc Interv] 2019 Jan 01; Vol. 93 (1), pp. 41-47. Date of Electronic Publication: 2018 Sep 30.
Typ publikacji:
Journal Article
MeSH Terms:
Percutaneous Coronary Intervention*/adverse effects
Percutaneous Coronary Intervention*/mortality
Anticoagulants/*therapeutic use
ST Elevation Myocardial Infarction/*therapy
Warfarin/*therapeutic use
Aged ; Anticoagulants/adverse effects ; Databases, Factual ; Female ; Hemorrhage/chemically induced ; Hospital Mortality ; Humans ; Length of Stay ; Male ; Middle Aged ; Retrospective Studies ; Risk Assessment ; Risk Factors ; ST Elevation Myocardial Infarction/diagnostic imaging ; ST Elevation Myocardial Infarction/mortality ; Time Factors ; Treatment Outcome ; Warfarin/adverse effects
Czasopismo naukowe
Tytuł:
The Next Generation of Physician-Scientists: Adapting to Academic Cardiology in the 21 Century.
Autorzy:
Marbach JA; CAPITAL Research Group, Division of Cardiology, Department of Medicine, University of Ottawa Heart Institute, Ottawa, Ontario, Canada. Electronic address: .
Almufleh A; CAPITAL Research Group, Division of Cardiology, Department of Medicine, University of Ottawa Heart Institute, Ottawa, Ontario, Canada; Cardiac Sciences Department, King Saud University, Riyadh, Saudi Arabia.
Froeschl M; CAPITAL Research Group, Division of Cardiology, Department of Medicine, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Hibbert B; CAPITAL Research Group, Division of Cardiology, Department of Medicine, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Pokaż więcej
Źródło:
The Canadian journal of cardiology [Can J Cardiol] 2018 Sep; Vol. 34 (9), pp. 1225-1228. Date of Electronic Publication: 2018 Aug 02.
Typ publikacji:
Journal Article
MeSH Terms:
Cardiology*/education
Cardiology*/trends
Education, Medical*/methods
Education, Medical*/trends
Biomedical Research/*education
Biomedical Technology/*education
Research Personnel/*education
Education/organization & administration ; Education/trends ; Humans ; Intersectoral Collaboration
Czasopismo naukowe
Tytuł:
Predicting Acute Kidney Injury following Transcatheter Aortic Valve Replacement.
Autorzy:
Marbach JA; Department of Cardiology, University of Ottawa Heart Institute. .
Feder J
Yousef A
Ramirez FD
Simard T
DiSanto P
Russo JJ
Boland P
Labinaz M
Glover C
Dick A
Hibbert B
Pokaż więcej
Źródło:
Clinical and investigative medicine. Medecine clinique et experimentale [Clin Invest Med] 2017 Dec 17; Vol. 40 (6), pp. E243-E251. Date of Electronic Publication: 2017 Dec 17.
Typ publikacji:
Journal Article
MeSH Terms:
Acute Kidney Injury/*diagnosis
Aortic Valve/*surgery
Transcatheter Aortic Valve Replacement/*adverse effects
Acute Kidney Injury/etiology ; Aged ; Aged, 80 and over ; Female ; Glomerular Filtration Rate/physiology ; Humans ; Logistic Models ; Male ; Multivariate Analysis ; Prospective Studies ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Multiple inappropriate implantable cardiac defibrillator therapies in rapid succession.
Autorzy:
Marbach JA; Division of Cardiology University of Ottawa Heart Institute Ottawa ON Canada.
Yeo C; Division of Cardiology University of Ottawa Heart Institute Ottawa ON Canada.
Green MS; Division of Cardiology University of Ottawa Heart Institute Ottawa ON Canada.
Nair GM; Division of Cardiology University of Ottawa Heart Institute Ottawa ON Canada.
Pokaż więcej
Źródło:
Clinical case reports [Clin Case Rep] 2017 Oct 23; Vol. 5 (12), pp. 1972-1975. Date of Electronic Publication: 2017 Oct 23 (Print Publication: 2017).
Typ publikacji:
Case Reports
Raport
Tytuł:
Novel treatments for familial hypercholesterolemia: pharmacogenetics at work.
Autorzy:
Marbach JA; Department of Medicine, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania.
McKeon JL
Ross JL
Duffy D
Pokaż więcej
Źródło:
Pharmacotherapy [Pharmacotherapy] 2014 Sep; Vol. 34 (9), pp. 961-72. Date of Electronic Publication: 2014 Jun 05.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Pharmacogenetics*
Anticholesteremic Agents/*therapeutic use
Hyperlipoproteinemia Type II/*drug therapy
Anticholesteremic Agents/pharmacology ; Benzimidazoles/pharmacology ; Benzimidazoles/therapeutic use ; Cholesterol, LDL/blood ; Drug Design ; Humans ; Hyperlipoproteinemia Type II/genetics ; Mutation ; Oligonucleotides/pharmacology ; Oligonucleotides/therapeutic use
Czasopismo naukowe
    Wyświetlanie 1-19 z 19

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies